Abstract: Hyperglycemia in diabetes mellitus due to pancreatic beta cell destruction can cause the raising of free radicals production. Soy isoflavone-containing diets have been reported to be beneficial in diabetes because they show potential antioxidant and antihyperglycemia activities. This study was conducted to analyze the difference between isoflavone aglycones in tempe and isoflavone glycosides in soymilk on beta cell function including insulin secretion, fasting blood glucose (FBG) and insulin expression of pancreatic beta cells. Thirty sprague dawley (SD) male rats were randomly divided into 3 following groups: (K1) diabetic control (P1) tempe flour 1.8 g (P2) soymilk powder 1.35 g. The treatment were given everyday for 28 days via oral gavage. FBG was measured using the GOD-PAP method, serum insulin was measured using ELISA, insulin expression analysis was done by immunohistochemical. Value of p less than 5% (p<0.05) was considered statistically significant. Tempe flour significantly decrease FBG level better than soy milk and control group (p<0.01). Although both groups showed an increase in serum insulin level after intervention, there was no significant different between them (p = 0.639). There were also a significantly decrease in FBG level on soymilk group compared to control (p<0.01). The mean insulin expression on K1, P1 and P2 were 2.67±2.34, 6.17±1.47 and 6.83±1.17, respectively. The insulin expression of both groups were not significantly different (p = 0.405). It is concluded that tempe flour shows a better anti-diabetic activity than soymilk.
INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic diseases marked by hyperglycemia due to the impairment o f insulin secretion, insulin action, or both (American Diabetes Association, 2010; Indonesian Endocrinology Association, 2013; International Diabetes Federation, 2014) . Secondary hyperglycemia due to diabetes is closely related to the damage and impairment to the functions of several associated organs including eyes, kidney and liver, resulting in various complication that influence the p atient's quality of life (International Diabetes Federation, 2014; American Diabetes Association, 2012) . Diabetes is a serious chronic disease in Indonesia. Based on data from the IDF in 2013, Indonesia was ranked seventh in the top 10 countries for number of people with diabetes (20-79 years) and is expected to rise to sixth rank in 2035 (International Diabetes Federation, 2014) . The result of Basic Health Research, from Indonesian Ministry of Health in 2007 showed that among the causes of death in Indonesia, diabetes ranks as the second highest cause of death, contributing to 14.7% nationwide (Research and Development Agency of Indonesian Ministry of Health, 2007) . Insulin is produced in specific amount to cater the metabolic requirements during healthy condition. Pancreatic beta cells can detect the change in blood sugar level and respond by releasing insulin. Decreased ability to sense and secrete insulin i n diabetics would result in the impairment of carbohydrate, fat and protein metabolism, often reflected b y dyslipidemia, which is prevalent among diabetics (Hsu et al., 2003) . In a person with diabetes, LDL particles transform to become smaller and denser as well as to (Food exchange list and diet planning for diabetes possess atherogenic features (Goldberg, 2001; mellitus, 2007) . The study utilized the standard of 3 American Diabetes Association, 2003) . To this date, vegetable-based protein exchanger unit that i s there has not been any pharmacologic agent that could equivalent with 150 g of tempe and 75 g of soy restore the function of insulin to glucose response. (Indonesian Nutritionist Associaton, 2002) . The amount Therefore, insulinotropic agent is highly necessary to was then converted to rat dosage (200 g) to acquire 2.7 help blood glucose control in diabetic patients (Gilbert g of tempe and 1.35 g of soy. Tempe processing into and Liu, 2013) . It has been reported that soy isoflavone powder resulted quantitative shrinking to 1/3 of the increases glucose and lipid metabolism through the original weight to produce a dosage of 1.8 g of tempe antidiabetic mechanism of PPAR (Peroxisome flour (Bintari, 2007) . The isoflavone content in 150 g of Proliferator-Activated Receptor), a receptor regulating tempe is approximately 154.05 and 160.5 mg in 75 g of gene transcription that plays a role in glucose and lipid soy (Nakajima et al., 2005; Song et al., 1998) . metabolism homeostasis in the cell. Soy isoflavone may increase insulin secretion without changing the blood Animals and diets: The samples used in this study is glucose level and may reduce the concentration o f male Sprague dawley rats aged 6-8 weeks with body adiponectin in the plasma in type 1 DM patients weight of 170-200 g obtained from PAU UGM. The (Kalaiselan et al., 2010) . Soy isoflavone extract also calculation of sample size was performed using Federer proven to improves glucose tolerance in diabetic rats formula and minimum sample size of 9 rats were (Shim et al., 2007) . Isoflavone genistein can protect the obtained. The rats were adapted for 7 days and fed with beta pancreatic cells from apoptosis as well a s standardized pellet diet. In this study, 30 rats were used stimulation its regeneration and proliferation (Gilbert and and grouped randomly into 3 groups, including: Liu, 2013) . During the process of fermentation, the betaglucosidase enzyme hydrolyzes isoflavone glycoside to K : Diabetic control group with the administration of form isoflavone aglycone, a more active form of Bavia et aquadest al. (2012) .
P1 : First intervention group with the administration of Based on these backgrounds, the authors will study the tempe flour at 1.8 g/day dissolved in 3 ml of water influence of soy administration in two preparation:
P2 : Second intervention group with the administration fermented soy in the form of tempe and unfermented soy of soymilk powder at 1.35 g/day dissolved in 3 ml in the form of soymilk powder, to the fasting glucose of water level, plasma insulin level and insulin expression in beta cell in the pancreas.
Induction of diabetic rats: The induction o f
MATERIALS AND METHODS

Study design:
The study is an experimental study with pre-post test randomized controlled group trial design. Tempe and soymilk powder preparation: The soy used in this study was the local variety soy from Grobogan (small district near Semarang, Central Java). The production of tempe was assisted by one of the tempe maker of Krobokan area in Semarang, who had received the training of hygienic tempe production from the Industry and Cooperative Business Agency of Semarang city, while the production of soy milk and tempe flour was conducted in Salatiga. The study used fresh tempe that has been fermented for 18-24 h using the methods of tempe making according to Bintari (Bintari, 2013) . Soy milk powder used in this study was produced using direct oil-free pan fry method (Indonesian P Ministry of Reaserch and Technology, 2013) . The standard of diabetes mellitus diet suggested the intake of 2-3 exchanger unit of vegetable protein a day hyperglycemic rat model in Szkudelski with STZ dosage of 65 g/kg of body weight and NA 230 mg/kg of body weight. SD rats were then weighed then the chosen ones were adapted for 7 days, placed in individual cages with the temperature of 28-32°C, adequate lighting (12 dark/light cycle). SD rats were subjected to 6 hours fasting ad libitum and then their blood was drawn from the retro orbital plexus to undergo fasting blood glucose level (FPG). SD rats were induced by STZ intra peritoneally then their FPG level was examined on the fifth day post-STZ induction and rats with blood glucose level of >200 mg/dL were chosen.
Measurement and analytical procedures:
The blood glucose level measurement was performed during the adaptation time, prior to and after the induction with STZ+NA and once a week during the study. The blood glucose level was measured with the GOD-PAP method using blood serum sample. The lipid profile examination was measured using the CHOD-PAP and GPO-PAP methods. The measurement of serum insulin level was performed before and after the intervention ends. Insulin level was measured using ELISA method in the GAKI Laboratory of Faculty of Medicine, Diponegor University Semarang using blood serum samples. The reagent DRG Insulin ELISA Kit with catalogue number EIA-2048 was used for insulin level examination.
Pancreatic biopsy:
The working principle of this method the soy milk intervention group with control group is staining pancreatic beta-cell for histologic analysis (p = 0.001) ( Table 7) . using the reagents mouse monoclonal antibody insulin primary antibody (beta subunit Ab-5, Clone: INSO5/2D11-H5) Cat.#1378 from NeoMarker Lab Vision. Allred score calculation was perfored manually using 400 time magnification in minimum field of 1 0 Langerhans island while counting the proportion score and intensity score. Allred score is the sum of proportion and intensity score ranged 0-8 (Allred, 1998) . Readings were performed by two independent experts. Statistical analysis: Data was analyzed using one way ANOVA and expressed in mean±SE. Statistical analyses were performed using SPSS Statistic 20. p-value <0.05 was considered significant.
RESULTS
There was a significant difference in initial body weight and body weight gain in experimental group during the experiment (p<0.01). Body weight in control group decreased significantly (p<0.01) during the treatment (Table 1 ). The fasting blood glucose level in tempe and soy milk groups underwent significant reduction each week (p<0.01). However, the reduction of blood glucose level in the tempe group was more significant than the reduction of blood glucose in the soy milk group (p<0.01). The control group that did not receive any intervention has an increase of blood glucose level each week (p<0.01) ( Table 2) . The fasting insulin level in the control group was increased, although the increase was not statistically significant (p = 0.118) ( Table 3) . The intervention group also demonstrated significantly increased fasting insulin level after tempe administration (p = 0.007) and soy milk (p = 0.003). However, there was no significant difference between the increase of fasting insulin level in the tempe group compared to the soy milk group (p = 0.0607). Based on Allred Score, The highest mean (6.83±1.17) of results was obtained in the group administered with soymilk ( Table 4 ). The expression of insulin from pancreatic beta cells between the tempe flour group and the soy milk group showed no significant difference (p = 0.405). The results showed that both the administration of soy tempe flour with the dose of 1.8 g/200 g body weight and the administration of soy milk with the dose of 1.35 g/200 g body weight for 28 days provided the same influence in fixing the damage to pancreatic beta cell due to STZ induction (Table 5) . The results of ANOVA analysis in the three groups for pancreatic beta-cell insulin expression showed p value of < 0.01 that could be concluded that there is a difference of beta cell insulin expression of pancreatic beta cells between the three study groups (Table 6 ). The significant group in this study is the tempe flour intervention group with the control group (p = 0.006) and (Sugano, 2005) . As with the Japanese, FDA has also allow several soy components with proven positive health effects to be mentioned in product wrappings (Yang et al., 2011) . Tempe is the product of soy fermentation with the help of the microorganism Rhizopus oligosporus. Tempe has been consumed by major of Indonesian population for more than 500 years and acknowledged as a national food (Yang et al., 2011; Kwon et al., 2010) . Soy fermentation increases the activity of antioxidants. The type and concentration of isoflavone produced during the fermentation process depends on the inoculum being utilized. The most commonly used inoculum include Rhizopus sp, M. luteus and Bacillus epidermis (Nout and Kiers, 2005) . During the fermentation, the enzyme beta-glucosidase hydrolyses isoflavone glycoside into isoflavone aglycone, a more active form of the substance (Bavia et al., 2012) . Soy isoflavone is a group of active biologic substances with estrogen-like chemical structure. Several epidemiological researches have associated high isoflavone consumption with decreased risk o f having diabetes and diabetes-related complications, including cardiovascular diseases. The evidence demonstrated that soy isoflavone has antihyperlipidemic effect through antioxidant mechanism, a function similar to that of estrogen and involved in the genes regulating lipogenesis and lipolysis (Lu et al., 2008) . Blood glucose level is also one of the indicators of hyperglycemia. STZ-induced rats demonstrated increased blood glucose level. STZ has a selective toxicity towards pancreatic cells and does not damage other endocrine cells or exocrine parenchyma. SD rats would have their blood analyzed on day 5 after STZ induction to measure the fasting blood glucose and if the results showed the value of >200 mg/dL, the SD rat would be determined as hyperglycemic (Szkudelski, 2012; Rachmawati, 2012) . Fasting blood glucose examination in this study is performed to monitor the development of SD rats during the intervention. STZ induction in this study is performed to create a model of type 1 diabetes mellitus mediated by the activity of immune system and cause delayed onset diabetes through beta-cell damages and immunologic injury. STZ administration damages the pancreatic beta cells, while NA administration is aimed to protect insulin secretion in balancing the action of STZ as a diabetogenic agent (Szkudelski, 2012) . STZ will be transported by beta cells through GLUT-2 and cause DNA damage and consequently increase the activity of poly ADP ribose polymerase (PARP-1) to repair DNA. The overactivity of PARP-1 results in intracellular depletion of NAD and ATP and hypersecretion of insulin + would result in necrosis. NA administration plays a role in the inhibition of PARP-1 and as the precursor NAD + and ATP exposed by STZ (Szkudelski, 2012) . STZ can cause the deaths of pancreatic beta cells through DNA alkylation, causing the DNA to break because of the activation of poly ADP-ribocylation, triggering the cellular NAD depletion and reducing ATP + content. This condition causes the inhibition of synthesis and secretion of insulin, then increasing the blood glucose level (Szkudelski, 2001) . High blood glucose level will increase oxidative stress through both enzymatic and non-enzymatic process. Changes in protein function, for example NAPH oxidase to disrupt and damage the cellular function and produce reactive oxygen intermediates that could oxidize LDL, occurred during the enzymatic process while nonenzymatic process will change gene expression (growth factor and cytokine) and disrupt antioxidant defenses (increasing oxidative stress) that eventually cause beta cell damage (Sheetz and King, 2002) . There are four isoflavone forms in soy, including (1) aglycone shapes (free form) including genistein, daidzein andglisitein, (2) glycosides including genistin, daidzin and glisetin, (3) acetyl glycosides including 6"-0-asetilgenistin, 6"-0-asetildaidzin and 6"-0-asetilglisetin, (4) malonilglycosides including 6"-0-malonilgenistin, 6"-0-malonildaidzin, 6"-0-malonilglisetin. Current studies have shown that isoflavone possesses antidiabetic activity through the glucose uptake inhibition in the intestinal brush border, the activity of alpha-glucosidase, tirosin kinase inhibitor and PPARalpha and PPAR-gamma agonist (Cheng et al., 2004) . The influence of soy isoflavone to the reduction of blood sugar level is thought to be caused by the stimulus of genistein to the beta pancreatic cells to increase the production of insulin to make it capable of increasing glucose uptake by cells (Esteves et al., 2011) . The influence is proven by the administration of genistein to experimental animals and in vitro studies using adipocytes and insulinoma cells, showing that the bioactive components formed from isoflavoneoid during fermentation process may activate a series of signals to stimulate insulin release (Kwon et al., 2011; Jonas et al., 1995) . Lee and Lee (2001) stated that the hypoglycemic effect of isoflavone to the blood glucose control in cases of diabetes is through the mechanism of alphaglucosidase inhibitor in the intestinal brush border (Lee and Lee, 2001 ). Lee's study (2006) to DM mice with the diet supplementation of genistein at 600 mg/kg and protein isolates at 200 mg/kg showed significant results to the reduction of blood glucose level and increased insulin level (Lee, 2006) . Alpha-glucosidase is the main enzyme in the process of carbohydrate digestion. alpha- glucosidase plays a role as the catalisator of hydrolysis The absorption of carbohydrate and glucose is the for 1,4-alpha-glycosides bonding existing in main target in blood glucose control. alpha-amylase carbohydrate and releases the alpha-glucose chain and and alpha-glucosidase are the main enzymes causing increased blood glucose level. Alpharesponsible for carbohydrate metabolism to form glucosidase inhibitor is antagonistic to the activity of glucose. Glucose is absorbed from intestinal alpha-glucosidase, thus it may delay the absorption of enterocytes by certain transporters. The inhibition of carbohydrate and suppress the increase of blood digestive enzymes may reduce glucose release and glucose level (Wu et al., 2012) . The results of McCue et absorption in the small intestines, which would result in al. study (2005) showed that soy fermented by Rhizopus the decrease of postprandial hyperglycemia (Hanhineva oligosporus yeast has a higher anti-alpha-glucosidase et al., 2010). compared to other soy products fermented by Lentinus The mechanism of blood glucose level reduction by soy edodes yeast (McCue et al., 2005) .
in all groups --------------------------------Groups --------------------------------
isoflavone, predominantly genistein and daidzein also
occurs through the peroxisome-proliferator activated secretion from the beta cells. Lee (2006) stated that receptor (PPAR). The activation of PPAR-gamma by genistein and daidzein causes an increase in gene expression that functions to code GLUT-4 and induce the upregulation of GLUT-4 needed as glucose transporter to enter the cells and utilized as energy source (Kavanagh et al., 2008; Cho, 2006) . The difference between fasting blood glucose reduction between the tempe flour group and soy milk group is caused by the form of isoflavone compound in both of these groups. Isoflavoneaglycone in tempe flour has a higher bioavailability compared to isoflavone glycosides in soy milk. Isoflavone is absorbed by the body in the form o f aglycone. The changes in isoflavone glycosides t o aglycone in tempe occurs during the fermentation process with the help of beta-glucosidase enzyme originated from Rhizopus oligosporus. Isoflavone aglycone can be detected in the blood 30 min after ingestion and reach its peak level 1 hour post-ingestion (Kwon et al., 2011; Day et al., 2000; Cassidy et al., 2006;  differentiation and apoptosis. The increase o f Larkin et al., 2008) . Isoflavone glycosides in soy milk can be changed into aglycone form with the help of beta-glucosidase enzyme and lactase phlorizin hydrolase (LPH) enzyme contained in the digestive system, especially in small intestines. The conversion of isoflavone glycosides into aglycone require 2-4 h post-ingestion. Isoflavone glycosides reaches its peak level 4-8 h post-ingestion. The study by Piskula et al. (1999) suggested that genistein and daidzein is absorbed more easily with the plasma concentration 4 times higher than the glycosides form. This proves that isoflavone aglycone in tempe flour is more effective in reducing fasting blood glucose level compared to isoflavone glycosides in soy milk (Hanhineva et al., 2010; Day et al., 2000; Cassidy et al., 2006; Larkin et al., 2008; Piskula et al., 1999) . The decrease in the sensitivity and secretion of insulin resulted in the blood glucose level disorder. To date, there has not been any pharmacologic agent that could restore the function of insulin response to the glucose response, thus the insulinotropic agent is urgently needed to help control blood glucose level in diabetic patients (Gilbert and Liu, 2013) . Genistein and daidzein increase insulin secretion in the administration o f certain dosage. Liu et al. (2006) suggested high-soyisoflavone diet (0.334 g/kg diet) may increase the production of insulin (Lu et al., 2008) . Soy isoflavone protects the beta pancreatic cells from glucose toxicity and improve the function of beta pancreatic cells. Preventing beta pancreatic cells from further damage may increase insulin secretion. The improvement o f serum insulin level in diabetic rats administered with soy products may also be used by other insulinotropic substances contained in soy, stimulating insulin genistein supplementation and soy protein in diabetic rats may improve insulin production (McCue et al., 2005) . Soy isoflavone protects pancreatic beta cells from blood glucose level. Hypoglycemic effects from genistein and soy protein are derived from serum insulin level and improvement of periphery glucose metabolism. Liu et al. (2006) and Fu et al. (2010) suggested that genistein modulates insulin secretion through the cAMP/PKA activation mechanism. Genistein induces the proliferation of INS1 and pancreatic beta cell islets through the signal of cAMP/PKA-dependent ERK1/2 activation pathway. Cyclic adenosine monophosphate (cAMP) is the central molecule in several cellular system and plays important role in insulin secretion. The accumulation of intracellular cAMP increases glucosemediated insulin secretion through the activation o f protein kinase A (PKA). Extracellular-regulated protein kinases (ERK1/2) plays a role in cellular responses stimulated by environment, like proliferation, intracellular cAMP activates ERK1/2, causing the beta cells to proliferate and protect itself from apoptosis that eventually increase insulin secretion (Liu et al., 2006; Fu et al., 2010) . The recovery of beta cell function is expected to derive from the improvement of blood glucose control, because hyperglycemia may interrupt with insulin response. In diabetes mellitus type 1 cases, the improvement o f insulin secretion is presumed to be preceded by the improvement of blood glucose control. The improvement of pancreatic beta cell function in type 1 diabetes mellitus cases may be initiated by improved blood glucose control that impacts the increase of insulin secretion and vice versa (Steele et al., 2004) . Insulin secretion by pancreatic beta cells involves several reaction that is a potential target to the role of isoflavone in diabetes mellitus. In the condition of high blood glucose level, pancreatic beta cells respond to the increase of insulin requirements through several mechanism, including increasing insulin secretion. The release of insulin from pancreatic beta cells is one of the chain reaction initiated by glucose uptake by GLUT-2 (Hanhineva et al., 2010) . Isoflavone as one of the flavonoids has a high antioxidant activity. Gilbert and Liu (2013) suggested that the role of isoflavone genistein to the function o f pancreatic beta cells is caused by the ability of genistein to stimulate regeneration of proliferation of beta cells. In diabetes, ROS is produced predominantly through the non-enzymatic glycation reaction (AGEs) that can occur to several tissues and cause complications in diabetes (Gilbert and Liu, 2013) . Blood glucose level reduction due to antioxidant causes the decrease of glucose toxicity and prevent the decrease of beta cell mass and insulin secretion (Kaneto et al., 1999) .
The result of King and Bursill (1998) 
